L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-|95399-71-6,AngeneChemical

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Pyrimidine, 5-bromo-2-methyl-

1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide

2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-

O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]

Tris(dibenzylideneacetone)dipalladium

C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C

Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-

Request for Quotation

Chemical Name:	L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,(4S)-
CAS Number:	95399-71-6
Product Number:	AG01CBC1(AGN-PC-0W4YQM)
Synonyms:
MDL No:
Molecular Formula:
Molecular Weight:

Identification/Properties
Safety Information
NMR Spectrum
Other Analytical Data
Customer Feedback

Identification/Properties

Computed Properties

Molecular Weight:

435.501g/mol

XLogP3:

3.8

Hydrogen Bond Donor Count:

Hydrogen Bond Acceptor Count:

Rotatable Bond Count:

Exact Mass:

435.217g/mol

Monoisotopic Mass:

435.217g/mol

Topological Polar Surface Area:

94.9A^2

Heavy Atom Count:

Formal Charge:

Complexity:

627

Isotope Atom Count:

Defined Atom Stereocenter Count:

Undefined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Undefined Bond Stereocenter Count:

Covalently-Bonded Unit Count:

Compound Is Canonicalized:

Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Quantity Required:*

Company Name:

Contact Person:*

Email:*

Tel:*

Country:*

Others:(Optional)

Verification Code:

Customer Feedback

Chemical Structure

Fosinoprilat, the active metabolite of Fosinopril, plays a crucial role in chemical synthesis as a potent angiotensin-converting enzyme (ACE) inhibitor. This compound is commonly utilized in the development of pharmaceuticals aimed at treating hypertension and heart failure. Its ability to inhibit ACE catalytic activity makes it a valuable tool in the synthesis of novel drug candidates designed to regulate blood pressure and improve cardiovascular health. By targeting the renin-angiotensin-aldosterone system, Fosinoprilat serves as a key component in the creation of medications that work to enhance cardiovascular function and combat related disorders.